Dianthus Therapeutics, INC. /De/ (DNTH) — 10-K Filings

All 10-K filings from Dianthus Therapeutics, INC. /De/. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

Dianthus Therapeutics Files 2024 10-K — Mar 11, 2025 Risk: medium
Dianthus Therapeutics, Inc. filed its 2024 10-K on March 11, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Magenta Therapeu
Dianthus Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — Mar 21, 2024 Risk: medium
Dianthus Therapeutics, Inc. /DE/ (DNTH) filed a Annual Report (10-K) with the SEC on March 21, 2024. Dianthus Therapeutics, Inc. filed its 2023 Form 10-K on Mar

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX